Table 4. Comparison of antimicrobial resistance of Salmonella Schwarzengrund, S. Manhattan and S. Infantis during the 2013–2016 study period.
| Antimicrobial agent | No. of resistant isolates (%) |
||
|---|---|---|---|
| S. Schwarzengrund | S. Manhattan | S. Infantis | |
| n=109 | n=263 | n=139 | |
| AMP | 0 (0.0) | 119 (45.2) | 29 (20.9) |
| CTX | 0 (0.0) | 109 (41.4) | 23 (16.5) |
| CFX | 0 (0.0) | 27 (10.3) | 15 (10.8) |
| CP | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| SM | 109 (100) | 257 (97.7) | 118 (84.9) |
| SUL | 102 (93.6) | 244 (92.8) | 117 (84.2) |
| OTC | 101 (92.7) | 238 (90.5) | 112 (80.6) |
| KM | 52 (47.7) | 3 (1.1) | 15 (10.8) |
| OFLX | 0 (0.0) | 0 (0.0) | 3 (2.2) |
| CTF | 0 (0.0) | 90 (34.2) | 22 (15.8) |
AMP, ampicillin; CTX, cefotaxime; CFX, cefoxitin; CP, chloramphenicol; SM, streptomycin; SUL, sulfamethoxazole; OTC, oxytetracycline; KM, kanamycin; OFLX, ofloxacin; CTF, ceftiofur.